Become A Featured Company

THC Global Group Limited (ASX:THC) Corporate Update – January 2019

Ryan Allway

January 31st, 2019

News

THC Global Group Limited (THC Global or the Company) (ASX:THC) (OTCMKTS:HDRPF) is pleased to provide an update on the Company’s activities as it transitions into full-scale domestic operations having secured almost all licencing and permitting required for its vertically integrated, Farm to Pharma business model.

Key Points:

– THC Global to transition to full-scale domestic operations upon finalisation of licencing and permitting

– Commenced cultivation following permitting for research and product validation at THC Global’s manufacturing and cultivation site in Queensland

– Appointment of new CFO – specialist in cross border and high-growth strategies

– Acquisition of Nova Scotia cultivation site to complete imminently with appointments of experienced management team for Vertical Canna Inc

– Expansion into New Zealand in December to be followed by strategic positions in the Asian markets – product export and medical engagement

– Hydroponics equipment distribution agreements for its proprietary trademarked products into the European Union secured with commencement in Q1 2019

– Patient enquiries received for epilepsy, autism, pain (neurological and chronic)

– Strong balance sheet – unaudited net equity $28.3 million

The Company has commenced cultivation activities having received permits for the cultivation and R&D site owned by THC Global subsidiary Canndeo. A Manufacturing licence for this site is expected shortly which will allow product validation and study trial production additionally to the full-scale manufacturing that THC Pharma will undertake at its other manufacturing facility.

In addition to the expansion into New Zealand in December, where THC Global is providing imported CBD products to patients in New Zealand under exclusive distribution agreements, THC Global is also exploring strategic opportunities to the broader Asian region. The Company expects to announce further details of these negotiations and early-stage partnerships as they develop towards commercial outcomes in the coming months.

The Company’s expansion into Canada with its wholly owned subsidiary Vertical Canna Inc has also been successful – with Vertical Canna focussing on acquiring assets with short revenue generation runways such as the Nova Scotia cultivation site, which is being positioned to not only be a cultivation site but also allow for retail and wholesale cannabis supply. The site is fully scalable, with the Company to expand growing capacity as it secures off-take agreements to underpin revenue targets.

In order to support the Company’s expanded activities globally, the Company appointed Mark Fortugno as Group Chief Financial Officer. Mark’s expertise will support the Company’s cross border acquisition activities and progression into full-scale production.

The Company’s balance sheet is stronger than ever, with an unaudited net equity of $28.3 million expected to be reported in the 2018 Annual Report to be released in the coming months.

THC Global’s hydroponics equipment division, Crystal Mountain, expects to grow significantly as the Company enters the retail market to supply to micro-cultivators and other new markets. The Crystal Mountain CEO, Jason Colquhoun has secured a number of new distribution agreements which will see distribution of Crystal Mountain’s trademarked products such as Spinpro to be distributed across the European Union commencing Q1 2019.

Revenue generation from the sale of imported cannabis products under the exclusive Endoca distribution agreement for Australia and New Zealand will also be more prominent in upcoming quarters as the Company continues prescriber, pharmacy, and patient engagement programs for the products sold by THC Pharma and THC Pharma (NZ). Patient enquiries have been primarily for epilepsy, autism, neurological pain and chronic pain.

Chief Executive Officer, Ken Charteris commented:

“Q4 2018 has been a pivotal quarter for the Company focussing on developing a vertically integrated global cannabis business and marking the Company’s transition into production mode as its domestic facilities receive final licencing and permitting required.

“We are pleased to see first plants on site at our manufacturing and cultivation site, and look forward to commencing the first stage of our manufacturing activities to support the domestic market with a view to our larger facility being used to pursue export opportunities.”

THC Global Group Limited ( ASX:THC ) ( OTCMKTS:HDRPF ) (FRA:9TH) operates under a ‘Farm to Pharma’ pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes. Having secured both a significant growing capacity over two grow sites, and an industry-leading pharmaceuticals biomanufacturing facility with attached testing and product development laboratory, THC Global is in prime position to service both domestic patients and the export market. THC Global’s commercial partners operate across four continents, supporting future international growth.

In addition to its core medicinal cannabis business, THC Global owns two Canadian companies, being Crystal Mountain Products and Vertical Canna Inc. Crystal Mountain Products operates a revenue generating global hydroponics retailer and distributor of equipment, material, and nutrients to cannabis growers and producers. Vertical Canna Inc is an investment vehicle through which THC Global intends to build, through acquisitions and strategic partnerships, a vertically integrated Canadian cannabis producer and retailer.

Media Enquiries

MMR Corporate Services

media@mmrcorporate.com
P: +61 2 9251 7177

 

 

 

 

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading